Navigation Links
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
Date:10/29/2009

SEATTLE, Oct. 29 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following upcoming investor conferences.

    Merriman Investor Summit 2009
    New York City
    Tuesday, November 10, 2009
    11:00 a.m. ET

    Credit Suisse 2009 Healthcare Conference
    Phoenix, Arizona
    Friday, November 13, 2009
    11:30 a.m. ET

    Lazard Capital Markets 6th Annual Healthcare Conference
    New York City
    Tuesday, November 17, 2009
    10:55 a.m. ET

The presentations will be audio webcast live and available for replay from Dendreon's website, www.dendreon.com.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit www.dendreon.com.

SOURCE Dendreon Corporation


'/>"/>
SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
2. Dendreon Announces Analyst Day Webcast Presentation to be Held on September 24, 2009
3. Dendreon Reports Second Quarter 2009 Financial Results
4. Dendreon Signs Lease for New Manufacturing Facility in Atlanta
5. Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET
6. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
7. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
8. Dendreon Announces Closing of Common Stock Offering
9. Dendreon Announces Common Stock Offering
10. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
11. Dendreon Reports First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... February 4, 2016 --> ... acceleration company is pleased to provide the following update on ... Over the last 3 months we have significantly increased ... agreements exceeding $1,000,000. As a result, we have positioned ourselves ... Inc. license agreement and expect that development to continue on ...
(Date:2/4/2016)... Feb. 4, 2016  Spherix Incorporated (Nasdaq: SPEX ... and monetization of intellectual property, today provided an update ... the Northern District of Texas ... Inter Partes Re-examination ("IPR") proceedings that ... The IPR was initiated on only certain claims of ...
(Date:2/4/2016)... ... February 04, 2016 , ... Franz Inc. , an ... technology has been recognized As “ Best in Semantic Web Technology - USA ... Corporate America, it’s our priority to showcase prominent professionals who are excelling in ...
(Date:2/4/2016)... ... ... Many of the engineers at FireflySci, Inc. have been manufacturing quartz and ... other cuvette manufacturers is their supercharged customer service and their extensive database of glass ... flow of inside information, they have recently revamped their manufacturing techniques to reduce lead ...
Breaking Biology Technology:
(Date:1/22/2016)... , Jan. 22, 2016 ... the addition of the "Global Biometrics ... to their offering. --> ... the "Global Biometrics Market in Retail ... --> Research and Markets ...
(Date:1/20/2016)... Jan. 20, 2016 A market that just ... benefit from the explosion in genomics knowledge. Learn all ... Research. A range of dynamic trends are pushing market ... personalized medicine - pharmacogenomics - pathogen evolution - next ... markets - greater understanding of the role of genetic ...
(Date:1/20/2016)... 20, 2016  Synaptics Incorporated (NASDAQ: SYNA ... today announced sampling of S1423, its newest ClearPad ... small screen applications including smartwatches, fitness trackers, and ... and rectangular shapes, as well as thick and ... moisture on screen, while wearing gloves, and supports ...
Breaking Biology News(10 mins):